Bank of New York Mellon
ZSAN

Bank of New York Mellon’s Zosano Pharma Corporation ZSAN Stock Holding History

Bank of New York Mellon’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,192
Closed -$52K – 4513
2021
Q1 		$52K Buy
+1,192
New +$49.9K ﹤0.01% 4253
2018
Q1 		– Sell
-72
Closed -$26K – 4438
2017
Q4 		$26K Buy
72
+14
+24% +$7.03K ﹤0.01% 4287
2017
Q3 		$33K Buy
58
+6
+12% +$4.4K ﹤0.01% 4171
2017
Q2 		$51K Hold
52
– – ﹤0.01% 4130
2017
Q1 		$69K Buy
+52
New +$62.8K ﹤0.01% 4099

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Bank of New York Mellon's ZSAN Position: Q2 2021 in Review

Bank of New York Mellon sold out of Zosano Pharma Corporation (ZSAN) in Q2 2021, closing a stake of 1,192 shares — an estimated $52K sold.

Bank of New York Mellon first reported a position in ZSAN in Q1 2017 and held it in 5 quarters. The position peaked at $69K in Q1 2017. 34 funds tracked by Wall St. Rank hold ZSAN as of Q2 2021.

  • Bank of New York Mellon reported no remaining Zosano Pharma Corporation position as of Q2 2021 after selling out during the quarter.
  • Bank of New York Mellon sold 1,192 Zosano Pharma Corporation shares in Q2 2021, an estimated $52K.
  • Bank of New York Mellon first reported a position in Zosano Pharma Corporation in Q1 2017 and held it in 5 quarters.
  • Bank of New York Mellon's Zosano Pharma Corporation position peaked at $69K in Q1 2017.
  • 34 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2021.

Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.